European Medicines Agency

EMA official suggests ditching AstraZeneca jab

A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published on June 13.

Marco Cavaleri, the EMA's head of vaccine strategy, also told Italy's La Stampa newspaper that the Johnson & Johnson jab should be preferentially used for the over 60s.

Vaccination of children could start soon

Ljubljana – The head of the national advisory group for Covid-19 vaccination, Bojana Beović, has said that following the European Medicines Agency’s (EMA) approval of the Pfizer/BioNTech vaccine for children aged 12 or more, the group will recommend vaccinating children, especially children suffering from chronic diseases.

Vaccine supply expected to improve as of next week

Ljubljana – After Slovenia’s vaccination centres reported they had been receiving fewer Covid-19 vaccines this week than they have ordered, the national vaccination logistics coordinator said on Wednesday that more doses would be available in June, and that a major shipment of the AstraZeneca vaccine was expected this Friday.

Minister expects EU to have enough vaccine in coming months

Brussels – The health minister expects that the EU will have enough Covid-19 vaccine in the coming months to fight off the pandemic, and that a digital green certificate will also play an important role. Its first version could be available in Slovenia in June, allowing residents to travel abroad over the summer, he said on Wednesday.

Bulgaria: Vaccination Green Corridors Will Continue Functioning

There are sufficient quantities of vaccines available in the country, deliveries are regularly carried out by all manufacturers. The "green corridors" for vaccination will continue to function. Director of the Bulgarian Drug Agency Bogdan Kirilov assured the arrival of another 273,780 doses of Pfizer/BioNTech COVID-19 vaccine will be on time.

Pages